Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells

Journal of Biological Chemistry

Volumn 290, Issue 6, 2015, Pages 3814-3824

  Lawn, Samuel ^a   Krishna, Niveditha ^b   Pisklakova, Alexandra ^b   Qu, Xiaotao ^b   Fenstermacher, David A ^b   Fournier, Michelle ^b   Vrionis, Frank D ^b,c   Tran, Nam ^a   Chan, Jennifer A ^a   Kenchappa, Rajappa S ^b,c   Forsyth, Peter A ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELLS; CHEMICAL ACTIVATION; CYTOLOGY; ENZYME INHIBITION; SIGNALING; TUMORS;

CELL VIABILITY; ERK ACTIVATION; MALIGNANT GLIOMA; NEUROTROPHIN RECEPTOR; NEUROTROPHIN-3; NEUROTROPHINS; P75 NEUROTROPHIN RECEPTOR; PHARMACOLOGICAL INHIBITION;

CELL SIGNALING;

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE A;

ARTICLE; CANCER GROWTH; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR PROMOTION; BRAIN TUMOR; CANCER STEM CELL; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GLIOMA; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; NEOPLASTIC STEM CELLS; NERVE GROWTH FACTORS; RECEPTOR, TRKB; RECEPTOR, TRKC;

EID: 84922350631     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.599373     Document Type: Article

References (39)

1. Chao, M. V. (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299-309
2. Reichardt, L. F. (2006) Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond.B Biol. Sci. 361, 1545-1564
3. Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., and Janzer, R. C. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459-466
4. Singh, S. K., Hawkins, C, Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., and Dirks, P. B. (2004) Identification of human brain tumour initiating cells. Nature 432, 396-401
5. Johnston, A. L., Lun, X., Rahn, J. J., Liacini, A., Wang, L., Hamilton, M. G., Parney, I. F., Hempstead, B. L., Robbins, S. M., Forsyth, P. A., and Senger, D. L. (2007) The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol. 5, e212
6. Wang, L., Rahn, J. J., Lun, X., Sun, B., Kelly, J. J., Weiss, S., Robbins, S. M., Forsyth, P. A., and Senger, D. L. (2008) 7-Secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor. PLoS Biol. 6, e289
7. Forsyth, P. A., Krishna, N, Lawn, S., Valadez, J. G., Qu, X., Fenstermacher, D. A., Fournier, M., Potthast, L., Chinnaiyan, P., Gibney, G. T., Zeinieh, M., Barker, P. A., Carter, B.D., Cooper, M. K., and Kenchappa, R.S. (2014) p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells. J. Biol. Chem. 289, 8067-8085
8. Wang, Y., Hagel, C, Hamel, W., Müller, S., Kluwe, L., and Westphal, M. (1998) Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma. Acta Neuropathol. 96, 357-364
9. Wadhwa, S., Nag, T. C, Jindal, A., Kushwaha, R., Mahapatra, A. K., and Sarkar, C. (2003) Expression of the neurotrophin receptors Trk A and Trk B in adult human astrocytoma and glioblastoma. J. Biosci. 28, 181-188
10. Assimakopoulou, M., Kondyli, M., Gatzounis, G., Maraziotis, T., and Varakis, J. (2007) Neurotrophin receptors expression and JNK pathway activation in human astrocytomas. BMC Cancer 7, 202
11. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068
12. Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., Rich, J. N. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760
13. Chen, J., Li, Y., Yu, T. S., McKay, R. M., Burns, D. K., Kernie, S. G., Parada, L. F. (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522-526
14. Kelly, J. J., Stechishin, O., Chojnacki, A., Lun, X., Sun, B., Senger, D. L., Forsyth, P., Auer, R. N., Dunn, J. F., Cairncross, J. G., Parney, I. F., and Weiss, S. (2009) Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells. 27, 1722-1733
15. Thiele, C. J., Li, Z., and McKee, A. E. (2009) On Trk: the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin. Cancer Res. 15, 5962-5967
16. Marchetti, D., Denkins, Y., Reiland, J., Greiter-Wilke, A., Galjour, J., Murry, B., Blust, J., and Roy, M. (2003) Brain metastatic melanoma: a neurotrophic perspective. Pathol. Oncol. Res. 9, 147-158
17. Nakagawara, A. (2001) Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett. 169, 107-114
18. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., and Greenberg, M. E. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362
19. Barker, P. A., and Shooter, E. M. (1994) Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA in PC12 cells. Neuron 13, 203-215
20. Wang, J., Hancock, M.K., Dudek, J. M., and Bi, K.(2008) Cellular assays for high-throughput screening for modulators of Trk receptor tyrosine kinases. Curr. Chem. Genomics 1, 27-33
21. Gallia, G. L., Tyler, B. M., Hann, C. L., Siu, I. M., Giranda, V. L., Vescovi, A. L., Brem, H., and Riggins, G. J. (2009) Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol. Cancer Ther. 8, 386-393
22. Eyler, C.E., Foo, W. C., LaFiura, K. M., McLendon, R.E., Hjelmeland, A.B., and Rich, J. N. (2008) Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 26, 3027-3036
23. Verhaak, R. G., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., Alexe, G., Lawrence, M., O'Kelly, M., Tamayo, P., Weir, B. A., Gabriel, S., Winckler, W., Gupta, S., Jakkula, L., Feiler, H. S., Hodgson, J. G., James, C. D., Sarkaria, J. N., Brennan, C., Kahn, A., Spellman, P. T., Wilson, R. K., Speed, T. P., Gray, J. W., Meyerson, M., Getz, G., Perou, C. M., Hayes, D. N., and Cancer Genome Atlas Research Network (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110
24. Hegi, M. E., Diserens, A. C., Bady, P., Kamoshima, Y., Kouwenhoven, M. C., Delorenzi, M., Lambiv, W. L., Hamou, M. F., Matter, M. S., Koch, A., Heppner, F. L., Yonekawa, Y., Merlo, A., Frei, K., Mariani, L., and Hofer, S. (2011) Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib: a phase II trial. Mol. Cancer Ther. 10, 1102-1112
25. Prados, M. D., Chang, S. M., Butowski, N., DeBoer, R., Parvataneni, R., Carliner, H., Kabuubi, P., Ayers-Ringler, J., Rabbitt, J., Page, M., Fedoroff, A., Sneed, P. K., Berger, M. S., McDermott, M. W., Parsa, A. T., Vandenberg, S., James, C. D., Lamborn, K. R., Stokoe, D., and Haas-Kogan, D. A. (2009) Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J. Clin. Oncol. 27, 579-584
26. Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., Chin, L., and DePinho, R. A. (2007) Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318, 287-290
27. Fan, X., Matsui, W., Khaki, L., Stearns, D., Chun, J., Li, Y. M., and Eberhart, C. G. (2006) Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66, 7445-7452
28. Sarangi, A., Valadez, J. G., Rush, S., Abel, T. W., Thompson, R. C., and Cooper, M. K. (2009) Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival. Oncogene 28, 3468-3476
29. Wu, G., Diaz, A. K., Paugh, B. S., Rankin, S. L., Ju, B., Li, Y., Zhu, X., Qu, C., Chen, X., Zhang, J., Easton, J., Edmonson, M., Ma, X., Lu, C., Nagahawatte, P., Hedlund, E., Rusch, M., Pounds, S., Lin, T., Onar-Thomas, A., Huether, R., Kriwacki, R., Parker, M., Gupta, P., Becksfort, J., Wei, L., Mulder, H. L., Boggs, K., Vadodaria, B., Yergeau, D., Russell, J. C., Ochoa, K., Fulton, R.S., Fulton, L. L., Jones, C., Boop, F. A., Broniscer, A., Wetmore, C., Gajjar, A., Ding, L., Mardis, E. R., Wilson, R. K., Taylor, M. R., Downing, J. R., Ellison, D. W., Zhang, J., Baker, S. J., and St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444-450
30. Jones, D. T., Hutter, B., Jäger, N., Korshunov, A., Kool, M., Warnatz, H. J., Zichner, T., Lambert, S. R., Ryzhova, M., Quang, D. A., Fontebasso, A. M., Stütz, A. M., Hutter, S., Zuckermann, M., Sturm, D., Gronych, J., Lasitschka, B., Schmidt, S., Seker-Cin, H., Witt, H., Sultan, M., Ralser, M., Northcott, P. A., Hovestadt, V., Bender, S., Pfaff, E., Stark, S., Faury, D., Schwartzentruber, J., Majewski, J., Weber, U. D., Zapatka, M., Raeder, B., Schlesner, M., Worth, C. L., Bartholomae, C. C., von Kalle, C., Imbusch, C. D., Radomski, S., Lawerenz, C., van Sluis, P., Koster, J., Volckmann, R., Versteeg, R., Lehrach, H., Monoranu, C., Winkler, B., Unterberg, A., Herold-Mende, C., Milde, T., Kulozik, A. E., Ebinger, M., Schuhmann, M. U., Cho, Y. J., Pomeroy, S. L., von Deimling, A., Witt, O., Taylor, M. D., Wolf, S., Karajannis, M. A., Eberhart, C. G., Scheurlen, W., Hasselblatt, M., Ligon, K. L., Kieran, M. W., Korbel, J. O., Yaspo, M. L., Brors, B., Felsberg, J., Reifenberger, G., Collins, V. P., Jabado, N., Eils, R., Lichter, P., Pfister, S. M., and International Cancer Genome Consortium PedBrain Tumor Project (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat. Genet. 45, 927-932
31. Frattini, V., Trifonov, V., Chan, J. M., Castano, A., Lia, M., Abate, F., Keir, S. T., Ji, A. X., Zoppoli, P., Niola, F., Danussi, C., Dolgalev, I., Porrati, P., Pellegatta, S., Heguy, A., Gupta, G., Pisapia, D. J., Canoll, P., Bruce, J. N., McLendon, R. E., Yan, H., Aldape, K., Finocchiaro, G., Mikkelsen, T., Privé, G. G., Bigner, D. D., Lasorella, A., Rabadan, R., and Iavarone, A. (2013) The integrated landscape of driver genomic alterations in glioblastoma. Nat. Genet. 45, 1141-1149
32. Bergami, M., Rimondini, R., Santi, S., Blum, R., Götz, M., and Canossa, M. (2008) Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior. Proc. Natl. Acad. Sci. U.S.A. 105, 15570-15575
33. Li, Y., Luikart, B. W., Birnbaum, S., Chen, J., Kwon, C. H., Kernie, S. G., Bassel-Duby, R., and Parada, L. F. (2008) TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59, 399-412
34. Cazorla, M., Prémont, J., Mann, A., Girard, N., Kellendonk, C., and Rognan, D. (2011) Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J. Clin. Invest. 121, 1846-1857
35. Bertrand, T., Kothe, M., Liu, J., Dupuy, A., Rak, A., Berne, P. F., Davis, S., Gladysheva, T., Valtre, C., Crenne, J. Y., and Mathieu, M. (2012) The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition. J. Mol. Biol. 423, 439-453
36. Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A., and Ginty, D. D. (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science. 286, 2358-2361
37. Xing, J., Ginty, D. D., and Greenberg, M. E. (1996) Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 273, 959-963
38. Xing, J., Kornhauser, J. M., Xia, Z., Thiele, E. A., and Greenberg, M. E. (1998) Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell. Biol. 18, 1946-1955
39. Atwal, J. K., Massie, B., Miller, F. D., and Kaplan, D. R. (2000) The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron. 27, 265-277